Back to Search
DON ISHMAEL, M.D.
M.D.
Specialist
NPI: 1396745733Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
9759(OK)
Research & Publications (2)
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.
PMID 14533444·Cancer Invest·2003
3-trial
Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.
PMID 12743987·Cancer Invest·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 230 N MIDWEST BLVD
MIDWEST CITY, OK 73110 - Phone
- (405) 737-8455
Quick Facts
- NPI
- 1396745733
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 2
Are you this provider?
Claim Your Profile